📰 Timothyc Dec News
Page 2 - Timothyc Dec News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Timothyc Dec. Real-time updates on events, politics, business and more.
October 16, 2023
Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and...
October 16, 2023
Jay is sharing his story of receiving an ADHD diagnosis and eventually finding his treatment approach with Qelbree15.7 million U.S. children, teens and adults estimated to have been diagnosed with...
October 9, 2023
ROCKVILLE, Md., Oct. 09, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...
September 10, 2023
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant...
September 10, 2023
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant medication in pediatric patients with...
September 1, 2023
ROCKVILLE, Md., Aug. 31, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...
August 21, 2023
ROCKVILLE, Md., Aug. 21, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...
May 31, 2023
ROCKVILLE, Md., May 31, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | May 31, 2023
April 25, 2023
ROCKVILLE, Md., April 25, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | June 18, 2023
April 25, 2023
25.04.2023 - ROCKVILLE, Md., April 25, 2023 (GLOBE NEWSWIRE) - Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today ...